ANA Highlights: Stroke Guidance in the COVID-19 Pandemic
During this 36-minute video, Dr. Thanh Nguyen takes us through the origin of COVID-19 and its impact on stroke care - both for patients and clinicians. Note: Dr. Nguyen obtained permission to use the images used in this presentation and offered disclosures at the start of the presentation. 
Category
Format
  • Video
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Participation
ANA Highlights: Huntington Disease Updates
In this 19-minute video, Dr. Jee Bang provides an overview of the current state of research and therapy for Huntington Disease. 
Category
Format
  • Video
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
ANA Highlights: Extraneuronal Phenotypes of Spinal Muscular Atrophy: Part 1
In this 12-minute video, Dr. Basil Darras, Professor of Neurology at Boston Children’s Hospital and Harvard Medical School, introduces the learner to spinal muscular atrophy (SMA), the number one genetic cause of death in infants.
Category
Format
  • Video
Credits
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Participation
ANA Highlights: Extraneuronal Phenotypes of Spinal Muscular Atrophy: Part 2
In part 2 of this series, Dr.
Category
Format
  • Video
Credits
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Participation
ANA Webinar: @ANA2020 Networking [Virtual Networking 101]
Hosted by Drs. Jason Hinman & Bhooma Aravamuthan, and featuring panelists Drs.
Category
Format
  • Video
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
ANA Webinar: MS DMTs during COVID-19
During this 60-minute session, Dr. John Ciotti hosted Drs.
Category
Format
  • Video
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
ANA Webinar: Mentoring K Awardees for Success
During this 90-minute session, Dr. Rebecca Gottesman moderated a panel discussion to explore questions related to successful mentorship of clinician-scientists. Dr.
Category
Format
  • Video
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Participation
ANA Webinar: Neurological Manifestations of COVID-19
During this 60-minute session, Drs. Ken Tyler and Igor Koralnik review updates on neurological manifestations of COVID-19 and answer questions related to the article on this topic in the July issue of the Annals of Neurology.
Category
Format
  • Video
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
ANA Highlights: Functional Movement Disorders: Advances in Pathophysiology and Treatment
Functional Movement Disorders (FMD) are as prevalent as Multiple Sclerosis (MS) yet remain understudied. Like MS, FMD predominantly affect women, has historically been referred to as “hysteria” or “conversion disorder” and remains a highly stigmatized condition. In this 43 minute video, Dr.
Category
Format
  • Video
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Participation
ANA Webinars: Meet the Authors: Adults with Cerebral Palsy Require Ongoing Neurologic Care (recorded)
Cerebral palsy (CP) does not end in childhood. NEW neurologic concerns can emerge in adults with CP which require ongoing neurologic surveillance and treatment.
Category
Format
  • Video
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Pages